Literature DB >> 2900912

Neuropeptide Y: a candidate neurotransmitter for biliary motility.

K D Lillemoe1, T H Webb, H A Pitt.   

Abstract

Neuropeptide Y (NPY) is a recently discovered polypeptide found in neurons throughout the gastrointestinal tract and in especially high concentrations in the biliary tree. This study was designed to test the functional significance of these high concentrations in the biliary tree by determining the effect of intravenous NPY on sphincter of Oddi and gallbladder motility. In adult male prairie dogs a side-hole, pressure-monitored perfusion catheter was placed through a choledochotomy into the duodenum and positioned in the sphincter of Oddi. A perfusion catheter was also placed in the gallbladder fundus. Sphincter of Oddi and gallbladder pressures were recorded before and during intravenous infusions of NPY at doses of 10, 100, and 500 ng/kg/min. Each dose was administered to seven separate animals. No effects were seen at the 10 or 100 ng/kg/min doses. NPY at the 500 ng/kg/min dose significantly increased sphincter of Oddi phasic wave frequency, amplitude, and motility index (MI = F X A). In addition, gallbladder pressure was significantly increased after 20 min of intravenous infusion of NPY at the 500 ng/kg/min dose. No significant changes in blood pressure were noted. These data suggest that in the prairie dog, systemic intravenous infusion of NPY significantly increases sphincter of Oddi phasic wave activity and gallbladder pressure. These findings are similar to those observed with intravenous cholecystokinin but opposite of those seen with peptide YY in this species. We hypothesize that neuropeptide Y may be an important neurotransmitter or neuromodulator regulating bile flow.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900912     DOI: 10.1016/0022-4804(88)90072-8

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  10 in total

1.  Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion.

Authors:  Sharon DeMorrow; Paolo Onori; Julie Venter; Pietro Invernizzi; Gabriel Frampton; Mellanie White; Antonio Franchitto; Shelley Kopriva; Francesca Bernuzzi; Heather Francis; Monique Coufal; Shannon Glaser; Giammarco Fava; Fanyin Meng; Domenico Alvaro; Guido Carpino; Eugenio Gaudio; Gianfranco Alpini
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-26       Impact factor: 4.249

Review 2.  Biliary motility.

Authors:  P A Grace; G J Poston; R C Williamson
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

3.  Metabolism and functions of neuropeptide Y.

Authors:  M dos S Medeiros; A J Turner
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

Review 4.  Gall stones and gall bladder motility.

Authors:  L J O'Donnell; P D Fairclough
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

Review 5.  Exercise and gall bladder function.

Authors:  A Utter; F Goss
Journal:  Sports Med       Date:  1997-04       Impact factor: 11.136

6.  Decreased gallbladder response in leptin-deficient obese mice.

Authors:  Matthew I Goldblatt; Deborah A Swartz-Basile; Carol L Svatek; Atilla Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

7.  Progesterone alters biliary flow dynamics.

Authors:  S Tierney; A Nakeeb; O Wong; P A Lipsett; S Sostre; H A Pitt; K D Lillemoe
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

8.  Neuropeptides in pig sphincter of Oddi, bile duct, gallbladder, and duodenum.

Authors:  J Sand; H Tainio; I Nordback
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

9.  Neuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms.

Authors:  Sharon DeMorrow; Fanyin Meng; Julie Venter; Dinorah Leyva-Illades; Heather Francis; Gabriel Frampton; Hae Yong Pae; Matthew Quinn; Paolo Onori; Shannon Glaser; Kelly McDaniel; Romina Mancinelli; Eugenio Gaudio; Gianfranco Alpini; Antonio Franchitto
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-23       Impact factor: 4.052

10.  Peptidergic innervation of human sphincter of Oddi.

Authors:  J Sand; H Tainio; I Nordback
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.